Camizestrant Advances as Targeted Oral Breast Cancer Therapy with Strong ESR1 Mutation Results

AstraZeneca’s next-generation oral selective estrogen receptor degrader (SERD) camizestrant continues to show promising progress as a targeted...

Nightseer Digital Night Vision Device Debuts with Innovative Optical Projection HUD on Kickstarter

Outdoor enthusiasts, hunters, and security professionals now have access to a groundbreaking night vision tool that promises...

Women Drive New Wave in Longevity and Sports Markets

Women are reshaping two of the fastest-growing sectors in wellness and fitness in 2026, filling long-standing gaps...

Newsletter

Want to be the first to know when new videos available? Subscribe to our weekly email newsletter.